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ISSObjective: Few studies have investigated the importance of different components of the
inflammasome system and of innate mitochondrial sensing (IMS) pathways in HIV
infection and its treatment. We analysed the expression of several components of the
inflammasome and of the IMS in HIV-positive patients taking successful combination
antiretroviral therapy (cART).
Methods: We enrolled 20 HIV-positive patients under cART, who achieved viral
suppression since at least 10 months and 20 age and sex-matched healthy donors.
By RT-PCR, using peripheral blood mononuclear cells (PBMCs), we quantified the
mRNA expression of 16 genes involved in inflammasome activation and regulation
(AIM2,NAIP, PYCARD, CASP1, CASP5,NLRP6,NLRP1,NLRP3, TXNIP, BCL2,NLRC4,
PANX1, P2RX7, IL-18, IL-1b, SUGT1) and eight genes involved in IMS (MFN2, MFN1,
cGAS, RIG-I, MAVS, NLRX1, RAB32, STING).
Results: Compared with controls, HIV-positive patients showed significantly lower
mRNA levels of the mitochondrial protein NLRX1, which plays a key role in regulating
apoptotic cell death; main PBMC subpopulations behave in a similar manner. No
differences were observed in the expression of inflammasome components, which
however showed complex correlations.
Conclusion: The decreased level of NLRX1 in HIV infection could suggest that the virus
is able to downregulate mechanisms linked to triggering of cell death in several immune
cell types. The fact that HIV-positive patients did not show altered expression of
inflammasome components, nor of most genes involved in IMS, suggests that the
infection and/or the chronic immune activation does not influence the transcriptional
machinery of innate mechanisms able to trigger inflammation at different levels.
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Pattern recognition receptors (PRRs) are proteins that
respond to pathogen-associated molecular patterns, and
endogenous stress signals termed danger-associated mol-
ecular patterns. PPRs comprise toll-like receptors (TLRs),
nucleotide-binding oligomerization domain (NOD)-like
receptors (NLRs), retinoic acid-inducible gene (RIG)-I-
like receptors (RLRs), absent in melanoma (AIM)-2-like
receptors (ALRs) and C-type lectin receptors (CLRs).
These molecules are central to the rapid innate immune
response and are crucial for starting adaptive immunity
responses [1]. Most intracellular NLRs [NOD, LRR and
pyrin domain-containing 1 (NLRP1), NLRP3, NLRP6,
or NOD, LRR and CARD-containing 4 (NLRC4)] can
assemble the inflammasome, which is a cytosolic, multi-
molecular platform that activates proinflammatory cyto-
kines such as interleukin-1b (IL-1b) and IL-18 via caspase-
1 (CASP1). Other proteins are able to assemble an
inflammasome, such as AIM2 or RIG-I (also known as
DDX58), that sense double-stranded DNA and RNA,
respectively [2]. RIG-I is also able to induce type I
interferon (IFN) responses via mitochondrial antiviral
signalling protein (MAVS) [3].
HIV infection is characterized by a persistent inflammatory
status, and indeed a low-grade, chronic level of
inflammation can be observed even in patients successfully
treated with combination antiretroviral therapy (cART)
[4]. The molecular mechanisms of this phenomenon, and
those that trigger or maintain inflammation are however
not clear. Until now, only few studies have investigated the
role of different components of the inflammasome system,
or the importance of innate mitochondrial (mt) sensing
pathways in HIV infection and its treatment. The aim of
the study was to analyse the expression of several, main
components of the inflammasomes and of the antiviral mt
sensing in HIV-positive patients taking successful cART.Materials and methods
Patients
The study was approved by the Institutional Review
Board of the Department of Surgery, Medicine, Dentistry
and Morphological Sciences of the University of Modena
and Reggio Emilia. We enrolled 20 HIV-positive patients
(18 men and two women; 47.5 11.9 years old;
mean SD) who took cART for 4.3 1.6 years, had a
CD4þ T cell count of 638.9 310.4 cells/ml and haveachieved viral suppression (i.e. undetectable plasma viral
load, below 50 copies/ml) for at least 10 months. All but
one patients were taking at least one nucleoside reverse
transcriptase inhibitors (NRTIs): eight abacavir/lamivu-
dine, two only lamivudine, 10 tenofovir/emtricitabine
and one zidovudine. As controls (CTR), we studied 20
age and sex-matched healthy donors (12 men and eight
women; 42.8 7.7 years old). All patients and controls
gave written informed consent for the studies described
here, according to the Italian laws.
Twenty millilitre of blood was collected from each
individual. Peripheral blood mononuclear cells (PBMCs)
were isolated, pelleted and stored at -808C, as described [5].
For the analysis of gene expression in different cell subsets,
CD14þmonocytes, CD19þ B cells, CD4þ Tand CD8þ
T cells were isolated from PBMCs of three healthy donors
and three HIV-positive patients by using magnetic sorting
(MACS, by Miltenyi, Bergisch Gladbach, Germany),
pelleted and stored at -808C. Purity was always more than
95%. Total RNA was extracted from thawed cells using
RNeasy Mini Kit (Qiagen Inc., Valencia, California,
USA). Cell viability, assessed with Live-dead AQUA
(Thermo Fisher, Waltham, Massachusetts, USA), on
Attune NxT Acoustic Focusing Cytometer (Thermo
Fisher) was more than 95% in all samples.
Gene expression analyses
We simultaneously quantified themRNAexpression of 16
genes involved in inflammasome activation (AIM2,NAIP,
PYCARD, CASP1, CASP5, NLRP6, NLRP1, NLRP3,
IL-18, IL-1b) or regulation (TXNIP, BCL2, NLRC4,
PANX1, P2RX7, SUGT1), and eight genes involved in
antiviral mitochondrial sensing (MFN2, MFN1, cGAS,
RIG-I, MAVS, NLRX1, RAB32, STING) by using a
prevalidated set of real-time PCR assays (PrimePCRassays
Bio-Rad Laboratories, Hercules, California, USA),
following provided instructions. We also measured three
housekeeping genes (HKG), that is ACTB, GADPH and
RLP13, and have chosen ACTB as the most stable gene,
required to calculate the relative mRNA gene expression.
Statistical analyses
Quantitative variables were compared with nonpara-
metric Mann–Whitney or Kruskal–Wallis tests. The
correlations between clinical parameters and molecular
data were performed by Spearman correlation test and
linear regression analysis. P values less than 0.05 were
considered statistically significant. Statistical analyses were
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Jolla, USA).Results and discussion
Inflammasomes are macromolecular platforms able to
control maturation and secretion of the proinflammatory
interleukins IL-1b and IL-18, and play a crucial role in
innate immune defenses. Inflammasomes exert several
other actions, such as the activation of inducible nitric
oxide synthase, regulation of autophagy or pyroptosis,
help in production of antibodies and activation of T cells.
However, only few data exist on the importance of
inflammasomes in HIV infection [6,7]. Thus, we
investigated mRNA expression of main components of
inflammasomes (sensors, adaptors, regulators and down-
stream signalling) and of the mitochondrial antiviral
signalling in PBMC from HIV-positive patients with
undetectable viremia.
Among genes involved in antiviral signalling and
regulation, we found that NLRX1 was differentially
expressed: HIV-positive patients showed significantly
lower levels of NLRX1 than healthy donors (Fig. 1a). We
then investigated different PBMC subpopulations and
found that NLRX1 expression was similar among1.5
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Fig. 1. Relative mRNA expression of the genes of the inflammasom
expression of NLRX1 in healthy donors (CTR) and patients with H
Whitney test. mRNA expression of NLRX1 relative to ATCB in PBMC
T lymphocytes in patients with HIV infection. Bars indicate mean vCD14þ monocytes, CD4þ and CD8þ T cells and
CD19þ B cells, either from HIV-positive patients
(Fig. 1b), or from healthy donors (not shown). NLRX1
is a still poorly characterized protein expressed in
mitochondria, previously identified as a negative reg-
ulator of mitochondrial antiviral signalling proteins
through a direct interaction on the cytosolic side of
the mitochondrial outer membrane [8]. Recently,
different roles and functions of NLRX1 have been
identified, such as overexpression of NLRX1 causes the
generation of reactive oxygen species [9]; NLRX1
controls apoptotic cell death in transformed cells [10];
NLRX1 can bind a small death-inducing protein from
influenza A virus and can protect immune cells against
virus-driven apoptosis [11]; NLRX1 dually regulates
IFN-I and autophagy through the engagement of the
mitochondrial protein named ‘Tu translation elongation
factor’ (TUFM). Reduction of both NLRX1 and TUFM
resulted in enhanced IFN-I activation, demonstrating a
partnership between NLRX1 and TUFM to control host
antiviral responses [12]. Thus, during HIV infection, the
decreased expression of NLRX1 could represent a yet
unknown mechanisms of viral escape from host restric-
tion factors. It is noteworthy that the decreased expression
was present at the same level in the main lymphocyte
populations (i.e. CD4þ and CD8þ T cells as well as in
CD19þ B lymphocytes) and in CD14þ monocytes.0002
HIV
D4+ CD8+ CD19+
es and mitochondrial viral sensing systems. Relative mRNA
IV infection (HIV) taking effective cART. P value by Mann–
s, CD14þmonocytes, CD19þ B cells and CD4þ T and CD8þ
alues with S.E.M.; P¼NS, as revealed by Kruskal–Wallis test.
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pathways, including NLRP3 (the scaffold component of
the best characterized inflammasome complex), was not
significantly different between HIV-positive patients and
controls (not shown). This could indicate that the
infection and/or the consequent chronic immune
activation do not influence the transcriptional machinery
of innate mechanisms able to trigger inflammation at
different levels. In other words, patients taking efficient
cART display the same level of basal inflammasome
activation of healthy individuals. In mice, nucleosidic
NRTIs block inflammation triggered by NLRP3
inflammasome by inhibiting the activity of P2RX7 [13].3
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Fig. 2. Correlations between the relative mRNA levels in perip
Correlations between the relative mRNA levels of SUGT1 (a) and
transcripts. P values have been obtained by linear regression analBlocking inflammation implies that the production of
pro-inflammatory cytokines is reduced. Accordingly, it
has been found that treating HIV-positive patients with
cART can reduce plasma levels of IL-18 [14]. Further
data, also performed by using functional assays, are
needed to better correlate the importance of inflamma-
some activation and the production of proinflammatory
cytokines during HIV infection. We did not find any
correlation between the expression of the genes we have
analysed and the viro-immunological parameters that
were collected during the routine clinical practice (CD4þ
T cell count and percentage, CD8þ T cell count and
percentage, CD4þ T cell nadir and CD4þ/CD8 ratio).D
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whose expression is not linked to IFN activity, showed
significant correlations (Fig. 2a and b, referred to as the
negative regulators SUGT1 and BCL2, respectively).
SUGT1 forms a chaperone complex with HSP90, which
maintains inactive, misfolded or used NLR-type sensors.
Similarly, the antiapoptotic BCL2 regulates the NLRP1
inflammasome [15]. Further studies are needed to
understand the reasons of such correlations that could
include the possible use of the same transcription factors,
or the presence of mutual interaction(s) between these
genes. Finally, we found that in HIV-positive patients,
other genes, belonging to the family of IFN-stimulated
genes (i.e. AIM2, CASP1, IL18, PANX1, MAVS,
MFN1, DDX58, CASP5, NAIP, PYCARD and the
small GTP-binding protein of the RAB family, RAB32),
were positively correlated among them (not shown).
We are well aware that this study presents some limitations,
first of all the relatively small sample size in which however
a broad panel of genes have been analysed. In any case, we
find that PMBC from HIV-positive patients taking
successful treatment display amarkedly different expression
of the gene for themitochondrial proteinNLRX1 and did
not show a differentially expression of components of the
inflammasome pathway, as well as of genes involved in the
antiviral mitochondrial sensing. Mitochondria are emer-
ging as a central platform for the assembly of signalling
complexes regulating inflammatory pathways. Changes in
the expression of theNLRX1,which is able to regulate the
cellular sensitivity to apoptotic signals, suggest a critical role
for this protein in several physiological processes and
pathological conditions, including HIV infection.Acknowledgements
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